Davids MS. BRUIN 313 and 314 Trials Open the Door for Noncovalent Bruton Tyrosine Kinase Inhibition as Initial Therapy for Chronic Lymphocytic Leukemia. J Clin Oncol 2025 Dec 9:JCO2502691. doi: 10.1200/JCO-25-02691.
PMID: 41363770